News and Announcements
OpenDNA (ASX: OPN) Rolls out Propriety Technology to Select Sectors
- Published September 26, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- OpenDNA has focused its engagement to sectors such as e-commerce, publishing and news, sports, recreation and leisure, business intelligence, analytics and telecommunications, to improve customer awareness and use of its artificial intelligence technology.
- The company’s Jottr App will soon be preloaded in the new Netsurfer handsets by Future Mobile Technology to provide cellphone users with personalised content the moment they but the phone.
- US-based online blogging website SportsBlog and Australian edition Robb Report is now also using OpenDNA’s artificial technology.
Open DNA Limited has rolled out its propriety technology on key industry sectors such as e-commerce, publishing and news, sports, recreation and leisure, business intelligence, analytics and telecommunications, to improve customer awareness.
These industries have been previously identified by the company as its core initial target sectors. These are sectors that have growth potential, a substantial number of customers worldwide and a high degree of consumer interaction.
Open DNA is an artificial intelligence company that got listed on the ASX in November of 2016. Since then, it has continuously worked on innovations that will allow the target business sectors to maximize their operations through the company’s technology.
In the past six months, OpenDNA has actively pursued engagements with the business intelligence and analytics sector such as Looker, Inc. which is considered one of Silicon Valley’s darlings. The company has integrated its artificial intelligence technology into the digital platforms of Looker. With the successful integration of the AI technology to its platforms, the salesforce of Looker is now able to promote and sell the the services of OpenDNA to their prospective and existing customers.
SportsBlog, an online sports blogging website based in the United States, and Robb Report Australian edition which is a publication focusing on luxury goods and activities, have started using OpenDNA’s software applications. The use of the Apps has yielded positive results with engagement figures up from the industry average of six minutes for a news App to 14 articles per session with an eight minutes session time.
OpenDNA’s App resulted to a 75% retention period for the said companies compared to the estimated average retention period in the industry. This result only validated the effectiveness of the personalization technology of the company.
The company has also recently updated the Jottr App which is available in both Android ad iOS formats. This App contains Facebook native ads and is capable of providing users with content from more than 250 sources on a variety of topics including sports, medicine, world news, finance, medicine and entertainment.
OpenDNA also entered into an agreement with Future Mobile Technology (FMT). The company is a manufacturer of Android handset and tablet including the Netsurfer smartphones with more than 500,000 users. Under the agreement, the new Netsurfer handsets will be pre-loaded with OpenDNA’s Jottr App, but subject to Google certification. This will provide users with personalised content the moment they get the phone.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
